Sutro's proprietary biochemical protein synthesis technology allows for rapid expression and functional screening of proteins that previously could not be produced due to limitations of other protein synthesis technologies.
Founded in 2004, Sutro Biopharma, Inc. has raised over $59M in funding since its inception. Current investors include SV Life Sciences, Alta Partners, Skyline Ventures, and Lilly Ventures.
Alta Partners is a leading venture capital firm in life sciences, funding over 120 companies in the industry since 1996. Alta's diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for our companies and our investors.
As an important component of Amgen's overall outreach strategy, Amgen Ventures invests in early-stage biotechnology companies focused on discovering and developing human therapeutics. The fund, which focuses primarily on areas of current therapeutic interest to Amgen, offers early-stage companies access to our extensive capabilities while providing us with insight into external research innovations that may pave the way for future collaborations.
Lilly Ventures, a stand-alone venture capital firm with its roots in the scientific tradition of Eli Lilly and Company, seeks to invest in great companies with compelling life science innovations and outstanding management teams in North America and Europe. Given the depth and breadth of the operational experience of our team, we actively partner with the management teams and co-investors of our portfolio companies at the seed, early and expansion stages. Lilly Ventures targets investments in biotechnology companies that leverage proprietary drug discovery or development technologies to build a multi-product pipeline that can have a meaningful impact on patient outcomes.
Skyline Ventures is a leading venture capital firm specializing in investing in outstanding product-focused healthcare companies. Skyline's areas of expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research.
SV Life Sciences is a venture capital adviser and manager that makes selected investments in businesses with experienced entrepreneurs and management teams. SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology and pharmaceuticals to medical devices & instruments, to healthcare information technology and services.
| Site Map